Presenting
Mercia Asset Management
Mercia Asset Management (MERC) is a proactive, specialist alternative asset manager with over £1.8billion in assets under management. The Group is focused on supporting regional SMEs to achieve their growth aspirations. Mercia provides capital across its four asset classes of venture, debt, private equity and proprietary capital: the Group's 'Complete Connected Capital'. The Group has a strong UK footprint through its regional offices, university partnerships and extensive personal networks, providing it with access to high-quality deal flow.
Open Orphan
Open Orphan (ORPH) is a rapidly growing niche CRO pharmaceutical services company which is the world leader in testing vaccines and antivirals through the use of human challenge clinical trials. Open Orphan is actively involved in the fight against COVID-19.
ReNeuron Group
ReNeuron Group (RENE) is a leading, clinical-stage stem cell business. Our primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need.